Jounce Therapeutics, Inc. Annual Return On Equity in % from 2017 to 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Jounce Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2017 to 2022.
  • Jounce Therapeutics, Inc. Return On Equity for the quarter ending December 31, 2022 was -30.9 %, a 12.2% increase year-over-year.
  • Jounce Therapeutics, Inc. annual Return On Equity for 2022 was -30.9 %, a 12.2% increase from 2021.
  • Jounce Therapeutics, Inc. annual Return On Equity for 2021 was -35.2 %, a 19.6% decline from 2020.
  • Jounce Therapeutics, Inc. annual Return On Equity for 2020 was -29.4 %, a 171% decline from 2019.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 -30.9 +4.29 +12.2% Jan 1, 2022 Dec 31, 2022
2021 -35.2 -5.77 -19.6% Jan 1, 2021 Dec 31, 2021
2020 -29.4 -70.7 -171% Jan 1, 2020 Dec 31, 2020
2019 41.3 +67 Jan 1, 2019 Dec 31, 2019
2018 -25.7 -16.2 -172% Jan 1, 2018 Dec 31, 2018
2017 -9.45 Jan 1, 2017 Dec 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.